Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
117.17
-0.06 (-0.05%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
73
74
Next >
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
June 25, 2024
Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
June 25, 2024
More than a half-dozen of Wall Street's most-successful billionaire investors dumped shares of Nvidia during the March-ended quarter and made these seven stocks their top buys.
Via
The Motley Fool
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
June 24, 2024
These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility.
Via
InvestorPlace
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Merck & Co
June 18, 2024
Via
Benzinga
Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
June 18, 2024
Via
Benzinga
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
June 22, 2024
Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend.
Via
Talk Markets
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
June 21, 2024
Find out about the top penny stocks to buy this year for a chance to see incredible results down the road as they soar to new heights.
Via
InvestorPlace
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
June 18, 2024
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...
Via
Benzinga
Exposures
COVID-19
Merck & Co Unusual Options Activity For June 14
June 14, 2024
Via
Benzinga
How Is The Market Feeling About Merck & Co?
June 11, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRK Options
June 07, 2024
Via
Benzinga
Comparative Study: Merck & Co And Industry Competitors In Pharmaceuticals Industry
June 04, 2024
Via
Benzinga
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
June 18, 2024
The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced...
Via
Benzinga
Exposures
Product Safety
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
June 17, 2024
These high-flying stocks could have more room to run if analysts are right.
Via
The Motley Fool
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth.
Via
InvestorPlace
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
June 11, 2024
These penny stocks to buy provide a good opportunity for investors to buy low-priced stocks that provide significant growth potential.
Via
InvestorPlace
3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year
June 11, 2024
High-yield dividend stocks can be resilient performers in long-term portfolios and provide steady income and robust growth in June.
Via
InvestorPlace
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
June 10, 2024
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.
Via
Talk Markets
From $10k to $100k: 3 Stocks With the Potential for Amazing Returns
June 10, 2024
Generate massive returns on investment with these three stocks to buy that have the potential to become market beaters in 2024 and beyond.
Via
InvestorPlace
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
June 10, 2024
Liz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey Capital...
Via
Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
If approved, this would be the first combination vaccine based on mRNA technology to hit the market.
Via
Investor's Business Daily
Exposures
COVID-19
Why Moderna Stock Is a No-Brainer Buy Right Now
June 10, 2024
This messenger-RNA pioneer should be able to keep its rebound going.
Via
The Motley Fool
3 Reasons to Buy Moderna Stock
June 08, 2024
The biotech hasn't said its last word.
Via
The Motley Fool
2 Dividend Stocks Billionaires Are Buying: Should You?
June 07, 2024
That's not a bad crowd to follow when investing in stocks.
Via
The Motley Fool
Exit Strategy: 3 Overvalued Stocks to Sell Before They Deflate
June 06, 2024
These are the overvalued stocks to sell. They represent quality companies that are worth buying after a 20% to 30% downside
Via
InvestorPlace
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
June 04, 2024
On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co...
Via
Benzinga
Large Cap BIopharmaceuticals Overview
June 03, 2024
As a defensive play healthcare is weighted at about 12% of the S&P 500.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
73
74
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.